Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment options for localized prostate cancer.
Keyes M, Crook J, Morton G, Vigneault E, Usmani N, Morris WJ. Keyes M, et al. Among authors: usmani n. Can Fam Physician. 2013 Dec;59(12):1269-74. Can Fam Physician. 2013. PMID: 24336537 Free PMC article. Review.
Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial.
Joseph K, Balushi MA, Ghosh S, Stenson T, Abraham A, Elangovan A, Warkentin H, Paulson K, Tankel K, Usmani N, Severin D, Schiller D, Wong C, Mulder K, Doll C, King K, Nijjar T. Joseph K, et al. Among authors: usmani n. Int J Radiat Oncol Biol Phys. 2023 Oct 1;117(2):434-445. doi: 10.1016/j.ijrobp.2023.04.023. Epub 2023 May 4. Int J Radiat Oncol Biol Phys. 2023. PMID: 37148982 Clinical Trial.
Canadian prostate brachytherapy in 2012.
Keyes M, Crook J, Morris WJ, Morton G, Pickles T, Usmani N, Vigneault E. Keyes M, et al. Among authors: usmani n. Can Urol Assoc J. 2013 Jan-Feb;7(1-2):51-8. doi: 10.5489/cuaj.218. Can Urol Assoc J. 2013. PMID: 23671495 Free PMC article.
2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So A, Usmani N, Vigneault E, Chi KN. Saad F, et al. Among authors: usmani n. Can Urol Assoc J. 2019 Oct;13(10):307-314. doi: 10.5489/cuaj.6136. Can Urol Assoc J. 2019. PMID: 31603409 Free PMC article. No abstract available.
2021 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So A, Usmani N, Vigneault E, Chi KN. Saad F, et al. Among authors: usmani n. Can Urol Assoc J. 2021 Feb;15(2):E81-E90. doi: 10.5489/cuaj.7074. Can Urol Assoc J. 2021. PMID: 33556313 Free PMC article. No abstract available.
2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).
Saad F, Aprikian A, Finelli A, Fleshner NE, Gleave M, Kapoor A, Niazi T, North SA, Pouliot F, Rendon RA, Shayegan B, Sridhar SS, So AI, Usmani N, Vigneault E, Chi KN. Saad F, et al. Among authors: usmani n. Can Urol Assoc J. 2022 Nov;16(11):E506-E515. doi: 10.5489/cuaj.8161. Can Urol Assoc J. 2022. PMID: 36378572 Free PMC article. No abstract available.
175 results